Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Products Articles

Community’s Positive Effect on Diabetes Management
Quick and Easy Does It With New Web-Based App
Smaller, Lighter OmniPod Earns FDA Approval
LifeScan Recall of all OneTouch Verio IQ Blood Glucose Meters in US
Tandem Announces Two Partnerships
Take Advantage of Diabetes Health's Special Deal With Living Social
Lilly Diabetes Supports Scholarship Fund With $100,000 Donation in 2013
Choosing an Insulin Pump: My Personal Debate
Mike Fisher, Competitive Snowboarder
Type 2: FDA OKs Canagliflozin But Has Concerns About Heart Risk
Diabetes Health Reference Charts
Type 2 Meds Reference Guide (PDF)
Mail Order Reference Guide (PDF)
Mail Order Reference Guide (PDF)
Infusion Sets Reference Guide (PDF)
Fast Acting Glucose Reference Guide (PDF)
See All Charts…
Products Archives
Browse the Products Archives
Subscribe to the Products RSS Feed
Print | Email | Share | Comments (0)

Heal Feet Faster


May 1, 1997

Magainin Pharmaceuticals Inc. recently announced successful results in phase III trials for FDA approval of Cytolex, their topical antibiotic cream for the treatment of foot ulcers.

After successful results in its first trial studies of Cytolex's use for treating infected foot ulcers in September 1996, Magainin entered into an agreement with SmithKline Beecham in February 1997 allowing them to develop, supply and market Cytolex in the United States.

"Our two studies represent, to our knowledge, the largest database of clinical information on infected diabetic foot ulcers that has been assembled," says Jay Moorin, chairman, president and chief executive officer of Magainin.

"If approved for marketing by the FDA, we expect that Cytolex will be the first antibiotic specifically labeled (by the FDA) for the treatment of infection in diabetic foot ulcers and will provide physicians an important alternative to systemic therapy."

Categories: Diabetes, Foot Care, Products

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - May 1, 1997

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.